GSK-3117391 - CAS# 1018673-42-1 Catalog No.:M6478-10 InChi: InChI=1S/C23H20ClN3O/c1-15-7-8-16(2)22(11-15)27-14-26-20-12-17(9-10-21(20)27)23(28)25-13-18-5-3-4-6-19(18)24/h3-12

InChi: InChI=1S/C23H20ClN3O/c1-15-7-8-16(2)22(11-15)27-14-26-20-12-17(9-10-21(20)27)23(28)25-13-18-5-3-4-6-19(18)24/h3-12

InChi: InChI=1S/C16H23N7O2/c1-20-14(24)13-19-23(16(20)25)8-3-2-7-21-9-11-22(12-10-21)15-17-5-4-6-18-15/h4-6

InChi: InChI=1S/C41H72O9

Formula: C16H20N6O

Of the cancer cell lines tested in the panel

GSK-3117391 - CAS# 1018673-42-1 Catalog No.:M6478-10 InChi: InChI=1S/C23H20ClN3O/c1-15-7-8-16(2)22(11-15)27-14-26-20-12-17(9-10-21(20)27)23(28)25-13-18-5-3-4-6-19(18)24/h3-12GSK 3117391, also known as GSK3117391A and HDAC IN 3, CAS No. 1018673 42 1, is a potent HDAC inhibitor for treating chronic inflammatory disorders. Product information CAS Number: 1018673 42 1 Molecular Weight: 403. 52 Formula: C22H33N3O4 Synonym: GSK3117391 GSK 3117391 GSK 3117391 GSK3117391A GSK 3117391A GSK 3117391A HDAC IN 3 HDAC IN3 HDAC IN 3 Chemical Name: cyclopentyl(S) 2 cyclohexyl 2 (((6 (3 (hydroxyamino) 3 oxopropyl)pyridin 3